Walleye Capital LLC Makes New $234,000 Investment in BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Walleye Capital LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,237 shares of the company’s stock, valued at approximately $234,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of BCAT. Penserra Capital Management LLC acquired a new position in shares of BlackRock Capital Allocation Term Trust during the third quarter worth about $15,901,000. Sanctuary Advisors LLC acquired a new position in shares of BlackRock Capital Allocation Term Trust during the second quarter worth about $2,967,000. Cambridge Investment Research Advisors Inc. boosted its holdings in BlackRock Capital Allocation Term Trust by 4.3% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company’s stock valued at $2,186,000 after purchasing an additional 5,438 shares in the last quarter. Blue Bell Private Wealth Management LLC boosted its holdings in BlackRock Capital Allocation Term Trust by 4.0% in the second quarter. Blue Bell Private Wealth Management LLC now owns 104,722 shares of the company’s stock valued at $1,718,000 after purchasing an additional 4,059 shares in the last quarter. Finally, Mathes Company Inc. boosted its holdings in BlackRock Capital Allocation Term Trust by 6.0% in the third quarter. Mathes Company Inc. now owns 96,500 shares of the company’s stock valued at $1,587,000 after purchasing an additional 5,500 shares in the last quarter. 36.12% of the stock is currently owned by hedge funds and other institutional investors.

BlackRock Capital Allocation Term Trust Stock Down 0.1 %

Shares of BCAT opened at $16.32 on Wednesday. The stock has a 50 day moving average price of $16.21 and a 200 day moving average price of $16.33. BlackRock Capital Allocation Term Trust has a 52-week low of $14.68 and a 52-week high of $17.18.

BlackRock Capital Allocation Term Trust Increases Dividend

The business also recently declared a monthly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 16th will be paid a dividend of $0.2892 per share. This represents a $3.47 annualized dividend and a dividend yield of 21.26%. The ex-dividend date is Monday, December 16th. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10.

Insiders Place Their Bets

In other news, major shareholder Saba Capital Management, L.P. sold 14,973 shares of the firm’s stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $16.41, for a total value of $245,706.93. Following the completion of the transaction, the insider now owns 16,302,733 shares in the company, valued at $267,527,848.53. This trade represents a 0.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Over the last quarter, insiders sold 723,927 shares of company stock worth $11,925,047.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

Featured Stories

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.